Da Jan Yang
Vorstandsvorsitzender bei ASCENTAGE PHARMA GROUP INTERNATIONAL
Aktive Positionen von Da Jan Yang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ASCENTAGE PHARMA GROUP INTERNATIONAL | Vorstandsvorsitzender | 01.05.2009 | - |
Vorsitzender | 01.05.2009 | - | |
Gründer | 01.05.2009 | - | |
Präsident | 01.05.2009 | - | |
Ascentage Pharma Group Corp. Ltd.
Ascentage Pharma Group Corp. Ltd. Pharmaceuticals: MajorHealth Technology Part of Ascentage Pharma Group International Co., Ltd., Ascentage Pharma Group Corp. Ltd. is a Chinese biopharmaceutical company. The company is based in Hong Kong, Hong Kong. The company was founded by Shao Meng Wang. | Direktor/Vorstandsmitglied | - | - |
Ascentage International Ltd. | Direktor/Vorstandsmitglied | - | - |
Shanghai Yasheng Pharmaceutical Technology Co., Ltd. | Direktor/Vorstandsmitglied | - | - |
Ascentage Pharma Group, Inc. | Direktor/Vorstandsmitglied | - | - |
Jiangsu Ascentage Pharma Pty Ltd. | Direktor/Vorstandsmitglied | - | - |
Ascentage Pharma Suzhou Co Ltd
Ascentage Pharma Suzhou Co Ltd Pharmaceuticals: MajorHealth Technology Part of Ascentage Pharma Group International Co., Ltd., Suzhou Ascentage Pharma Co., Ltd. is a pharmaceutical company. Suzhou Ascentage Pharma Co., Ltd. is based in Suzhou, China. The Chinese company was founded in 2016 by Guang Feng Wang. The CEO is Da Jan Yang. | Vorstandsvorsitzender | - | - |
Vorsitzender | - | - |
Karriereverlauf von Da Jan Yang
Ehemalige bekannte Positionen von Da Jan Yang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Ascenta Therapeutics, Inc. (California) | Direktor/Vorstandsmitglied | 01.01.2005 | 01.01.2008 |
Vorstandsvorsitzender | 01.01.2005 | 01.01.2008 | |
Technik-/Wissenschafts-/F&E-Leiter | 01.01.2004 | 01.01.2008 | |
Gründer | 01.01.2004 | 01.01.2008 | |
Sun Yat-Sen University | Direktor/Vorstandsmitglied | 01.09.2003 | 01.09.2006 |
Corporate Officer/Principal | 01.09.2003 | 01.09.2006 | |
░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Da Jan Yang
Sun Yat-Sen University | Undergraduate Degree |
Michigan State University | Doctorate Degree |
Statistik
International
China | 5 |
Vereinigte Staaten | 5 |
Hong Kong | 3 |
Operativ
Director/Board Member | 7 |
Chief Executive Officer | 3 |
Chairman | 2 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ASCENTAGE PHARMA GROUP INTERNATIONAL | Health Technology |
Private Unternehmen | 9 |
---|---|
Ascentage Pharma Group Corp. Ltd.
Ascentage Pharma Group Corp. Ltd. Pharmaceuticals: MajorHealth Technology Part of Ascentage Pharma Group International Co., Ltd., Ascentage Pharma Group Corp. Ltd. is a Chinese biopharmaceutical company. The company is based in Hong Kong, Hong Kong. The company was founded by Shao Meng Wang. | Health Technology |
Ascentage International Ltd. | |
Shanghai Yasheng Pharmaceutical Technology Co., Ltd. | |
Ascentage Pharma Group, Inc. | |
Jiangsu Ascentage Pharma Pty Ltd. | |
Ascenta Therapeutics, Inc. (California) | |
S*BIO Pte Ltd.
S*BIO Pte Ltd. Pharmaceuticals: MajorHealth Technology S*BIO is a privately-held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer with leading programs around histone deacetylases (HDAC) and kinases. S*BIO's lead candidate, SB939, entered the clinic in 2007. SB1518, S*BIO's potent and orally-active JAK2 inhibitor, entered the clinic in 2008 and has received orphan drug designation from the U.S. FDA. S*BIO has entered into a development collaboration, and option & license agreement with Onyx Pharmaceuticals, Inc. to develop and commercialize SB1518 and its other novel JAK2 inhibitor, SB1578. S*BIO's SB1317, a novel multikinase inhibitor, is in pre-clinical development and under a worldwide exclusive license with Tragara Pharmaceuticals, Inc. for its development and commercialization. In line with its vision to be a leading fully-integrated oncology-focused biotech company in Asia Pacific, S*BIO has established a state-of-the-art R&D infrastructure, complemented by a strong clinical development team. S*BIO has strong links with a network of medical oncologists in Asia Pacific and its investors include EDB Investments' biomedical sciences subsidiary Bio*One Capital, Aravis Ventures, Novartis Bioventures and other international funds. In 2009, S*BIO received the BioSpectrum Editor's Choice, Emerging BioScience Company of Singapore Award. | Health Technology |
The Chinese Biopharmaceutical Association | |
Ascentage Pharma Suzhou Co Ltd
Ascentage Pharma Suzhou Co Ltd Pharmaceuticals: MajorHealth Technology Part of Ascentage Pharma Group International Co., Ltd., Suzhou Ascentage Pharma Co., Ltd. is a pharmaceutical company. Suzhou Ascentage Pharma Co., Ltd. is based in Suzhou, China. The Chinese company was founded in 2016 by Guang Feng Wang. The CEO is Da Jan Yang. | Health Technology |
- Börse
- Insiders
- Da Jan Yang
- Erfahrung